(MRM) Medirom Healthcare - Ratings and Ratios

Exchange: NASDAQ • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US58510H1032

MRM: Massage, Therapy, Fitness, Healthcare, Beauty, Guidance, Wellness

MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) operates as a holistic health services provider in Japan, targeting diverse consumer needs across three core segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment, under Re.Ra.Ku and Ruam Ruam, offers therapies like finger-pressure bodywork and posture alignment, appealing to busy professionals seeking stress relief. The Digital Preventative Healthcare segment leverages technology, such as the Lav app and MOTHER Bracelet, to provide telehealth services, attracting health-conscious individuals. The Luxury Beauty segment, under ZACC, caters to high-end clients with premium salon services.

The companys strategic focus includes expansion through franchising and continuous training at Re.Ra.Ku College, enhancing customer service and operational efficiency. Their services are culturally tailored to Japans wellness trends, integrating traditional therapies with modern technology. This blend reflects a commitment to innovation and customer-centric care.

From a technical standpoint, MRMs stock shows a downtrend, trading below its SMA 20 and SMA 50 at $0.64, with low volatility indicated by an ATR of 0.07. Fundamentally, the high P/B ratio of 13.24 and a RoE of 323 suggest efficient equity use, though the lack of profitability is concerning. The 3-month forecast predicts continued decline due to bearish technicals and high valuation, with potential interest from growth investors despite profitability concerns.

Additional Sources for MRM Stock

MRM Stock Overview

Market Cap in USD 5m
Sector Consumer Cyclical
Industry Personal Services
GiC Sub-Industry Health Care Services
IPO / Inception 2020-12-29

MRM Stock Ratings

Growth 5y -89.3%
Fundamental 38.3%
Dividend 0.0%
Rel. Strength Industry -88.1
Analysts -
Fair Price Momentum 0.44 USD
Fair Price DCF -

MRM Dividends

No Dividends Paid

MRM Growth Ratios

Growth Correlation 3m -95.3%
Growth Correlation 12m -93.7%
Growth Correlation 5y -90.1%
CAGR 5y -51.85%
CAGR/Max DD 5y -0.54
Sharpe Ratio 12m -1.12
Alpha -101.09
Beta 1.37
Volatility 53.24%
Current Volume 15454k
Average Volume 20d 25.5k
What is the price of MRM stocks?
As of March 15, 2025, the stock is trading at USD 0.70 with a total of 15,453,955 shares traded.
Over the past week, the price has changed by +4.48%, over one month by -12.50%, over three months by -32.69% and over the past year by -87.97%.
Is Medirom Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Medirom Healthcare (NASDAQ:MRM) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.25 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRM as of March 2025 is 0.44. This means that MRM is currently overvalued and has a potential downside of -37.14%.
Is MRM a buy, sell or hold?
Medirom Healthcare has no consensus analysts rating.
What are the forecast for MRM stock price target?
According to ValueRays Forecast Model, MRM Medirom Healthcare will be worth about 0.5 in March 2026. The stock is currently trading at 0.70. This means that the stock has a potential downside of -27.14%.
Issuer Forecast Upside
Wallstreet Target Price 5.2 638.6%
Analysts Target Price - -
ValueRay Target Price 0.5 -27.1%